From Casetext: Smarter Legal Research

Khoja v. Orexigen Therapeutics, Inc.

United States District Court, Southern District of California
Oct 12, 2021
15-cv-00540-JLS-AGS (S.D. Cal. Oct. 12, 2021)

Opinion

15-cv-00540-JLS-AGS

10-12-2021

KARIM KHOJA, et al., Plaintiffs, v. OREXIGEN THERAPEUTICS, INC., et al., Defendants.


ORDER GRANTING JOINT MOTION TO APPEAR BY TELEPHONE OR VIDEOCONFERENCE FOR THE OCTOBER 28, 2021 HEARING ON MOTION FOR FINAL APPROVAL OF SETTLEMENT AND ATTORNEYS' FEES

[ECF NOS. 147; 151]

HONORABLE JANIS L. SAMMARTINO, UNITED STATES DISTRICT JUDGE

Presently before the Court is a Joint Motion wherein the parties request that the Court convert the October 28, 2021 in-person Motion Hearing on Plaintiffs' Unopposed Motion for Final Approval of Settlement and Plan of Allocation and Motion for an Award of Attorneys' Fees and Litigation Expenses to a telephonic or videoconference hearing. (ECF No. 151.) In their Joint Motion, the parties represent that good cause exists to convert the in-person Motion Hearing because of “the ongoing COVID-19 pandemic and the related risks arising from an in-person appearance.” (Id. at 2.)

Good cause appearing, the parties' Joint Motion is hereby GRANTED, and the October 28, 2021 in-person Motion Hearing (ECF No. 147) is hereby CONVERTED to a videoconference hearing. To facilitate their appearance at the Motion Hearing by videoconference, the parties shall contact the Court's Courtroom Deputy by e-mail at alexramos@casd.uscourts.gov.

IT IS SO ORDERED.


Summaries of

Khoja v. Orexigen Therapeutics, Inc.

United States District Court, Southern District of California
Oct 12, 2021
15-cv-00540-JLS-AGS (S.D. Cal. Oct. 12, 2021)
Case details for

Khoja v. Orexigen Therapeutics, Inc.

Case Details

Full title:KARIM KHOJA, et al., Plaintiffs, v. OREXIGEN THERAPEUTICS, INC., et al.…

Court:United States District Court, Southern District of California

Date published: Oct 12, 2021

Citations

15-cv-00540-JLS-AGS (S.D. Cal. Oct. 12, 2021)